Volume 56, Issue 1, Pages 49-54 (January 2012) Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: A retrospective repeated liver biopsy analysis  Patrick Ingiliz, Marc-Antoine Valantin, Paul Preziosi, Laetitia Finzi, Raluka Pais, Larysa Fedchuk, Stéphanie Dominguez, Christine Katlama, Thierry Poynard, Yves Benhamou  Journal of Hepatology  Volume 56, Issue 1, Pages 49-54 (January 2012) DOI: 10.1016/j.jhep.2011.05.028 Copyright © 2011 European Association for the Study of the Liver Terms and Conditions

Fig. 1 Liver fibrosis staging at the first and the last biopsy according to treatment and treatment outcome. Liver fibrosis Metavir stage (n, % of patients) at first and last biopsy in (A) untreated, (B) non-responders/relapsers, and (C) sustained virological responders to hepatitis C therapy. Fibrosis remained stable in patients on the shaded diagonal, worsened in those on the right side of this line and improved in those on the left side. Journal of Hepatology 2012 56, 49-54DOI: (10.1016/j.jhep.2011.05.028) Copyright © 2011 European Association for the Study of the Liver Terms and Conditions